Myocardial Injury vs Infarction Interpreter
Myocardial Injury vs Infarction Interpreter
A raised troponin is myocardial injury. Infarction needs acute injury plus evidence of ischaemia — and then a category. Built on the Fifth Universal Definition of Myocardial Infarction (2026), which replaced types 1 to 5 with primary, secondary and procedure-related.
Injury, infarction, and which category
Troponin + serial pattern + ischaemiaTroponin above the assay’s sex-specific 99th percentile. A rise and fall across two samples. Ischaemic chest discomfort with new lateral ST depression. The patient is in fast atrial fibrillation with sepsis, and a bedside echocardiogram shows a new regional wall motion abnormality
The definition, in the order it has to be applied
2. With a rise and/or fall → acute myocardial injury. Without one → chronic.
3. Acute injury plus evidence of acute myocardial ischaemia → myocardial infarction.
4. Then, and only then, the category: primary, secondary or procedure-related.
- Myocardial injury
- “An elevated cardiac troponin I or T level with at least one value above the 99th percentile upper reference limit (URL) regardless of the underlying cause” — Fifth Universal Definition of Myocardial Infarction, 2026
- Acute myocardial injury
- “A rise and/or fall in cardiac troponin I or T with at least one value above the sex-specific 99th percentile URL”. The sex-specific requirement is new in the Fifth and exists because a shared cut-off under-recognises injury in women
- Evidence of ischaemia
- “symptoms or other evidence of acute myocardial ischaemia that include new ischaemic changes or pathological Q waves on the electrocardiogram (ECG); imaging evidence of an acute coronary pathology; or new loss of viable myocardium or a new regional wall motion abnormality in a pattern consistent with an ischaemic aetiology”
- What this page cannot see
- the ECG, the echocardiogram and the coronary anatomy. It asks you what they showed; it does not read them. Nor does it know your assay, whose 99th percentile and whose delta are the numbers every judgement above depends on
Worked example
Troponin above the assay's sex-specific 99th percentile. A rise and fall across two samples. Ischaemic chest discomfort with new lateral ST depression. The patient is in fast atrial fibrillation with sepsis, and a bedside echocardiogram shows a new regional wall motion abnormality
Troponin above the 99th percentile → myocardial injury
A rise and fall across serial samples → the injury is acute, not chronic
Ischaemic symptoms with new ischaemic ECG changes → acute injury plus ischaemia → myocardial infarction
No acute coronary pathology; an acute non-coronary illness — sepsis with a tachyarrhythmia — is driving an oxygen supply–demand imbalance
The Fifth Universal Definition additionally requires obstructive coronary disease without acute coronary pathology and/or a new regional wall motion abnormality. The echocardiogram supplies it → secondary myocardial infarction
Now take the echocardiogram away. The same patient with the same troponin and the same ECG no longer satisfies the Fifth's criteria for secondary infarction — it becomes an infarction whose category is not established. Under the Fourth Universal Definition it would have been a type 2 either way
And the treatment follows the category, not the troponin: rate control, antibiotics and fluid resuscitation, not the acute coronary syndrome pathway
Injury and infarction are different findings
| Finding | Troponin above the 99th percentile? | Rise and/or fall? | Evidence of ischaemia? | What it is |
|---|---|---|---|---|
| No myocardial injury | No | — | — | Nothing to classify |
| Chronic myocardial injury | Yes | No | Not required | A stable, real abnormality with prognostic weight. Not an infarction |
| Acute myocardial injury | Yes | Yes | No | An active process — myocarditis, takotsubo, sepsis, pulmonary embolism, arrhythmia, critical illness. Not an infarction |
| Myocardial infarction | Yes | Yes | Yes | Infarction. Now establish the category |
The Fifth Universal Definition’s categories, against the Fourth’s numbers
| Fifth UDMI (2026) | Fourth UDMI (2018) | What changed |
|---|---|---|
| Primary myocardial infarction | Type 1 | Widened from atherothrombosis alone to all acute coronary pathologies — atherothrombosis, spontaneous coronary artery dissection, coronary embolism, vasospasm, and restenosis, stent thrombosis or graft failure more than 30 days after a procedure |
| Secondary myocardial infarction | Type 2 | Tightened. Supply–demand imbalance is no longer sufficient on its own: obstructive coronary disease without acute coronary pathology, and/or a new or presumed new regional wall motion abnormality or absence of viable myocardium, is now required |
| — (term removed) | Type 3 | Removed, for “limited use in clinical practice”. Type 3 was cardiac death with ischaemic symptoms before biomarkers could be obtained |
| Procedure-related myocardial infarction | Types 4a, 4b, 4c and 5 | Unified into one category with one set of criteria for all cardiac procedures, within 30 days. The Fourth’s separate troponin multiples — above five times the 99th percentile for type 4a, above ten times within 48 hours for type 5 after bypass surgery — are replaced by a requirement for a coronary complication and/or a new wall motion abnormality |
| Sex-specific 99th percentile | Single 99th percentile | Now part of the definition of injury, “to avoid systematic bias” and under-recognition in women |
| MINOCA | MINOCA | Redefined as “myocardial injury with non-obstructive coronary arteries” and treated as a working diagnosis rather than a conclusion |
The distinction the definition exists to draw, and the one most often collapsed
High-sensitivity troponin assays did something nobody entirely intended. They made it possible to detect myocardial injury in a large fraction of acutely unwell people, and in doing so they severed the link — which had held for a generation — between a positive cardiac biomarker and a coronary event. The Universal Definition exists to restore that link explicitly rather than by assumption. Its central claim is short and constantly forgotten: a troponin above the 99th percentile upper reference limit is myocardial injury, whatever caused it. It is not a diagnosis, it is a finding. Myocardial infarction is a narrower thing that requires two further conditions — that the injury be acute, demonstrated by a rise and/or fall across serial samples, and that it sit alongside evidence of acute myocardial ischaemia. Skip either condition and you have relabelled a raised troponin as a heart attack, which is the commonest error in this whole area and one that puts patients on antiplatelet therapy they do not need and leaves the illness that actually raised the troponin untreated.
The scale of the problem is not small. In unselected hospitalised patients, acute non-ischaemic myocardial injury and secondary infarction together account for around half of all measurable troponin elevations, and in one cohort of nearly 5,700 hospitalised patients, 62% had an abnormal high-sensitivity troponin while only 6.1% ended up with a diagnosis of type 1 infarction. Secondary infarction occurs more frequently than primary infarction, and above the age of 75 the two are at least equally prevalent. None of that makes the raised troponin unimportant — chronic myocardial injury carries real prognostic weight and acute non-ischaemic injury carries more — but it does mean that the default reading of a raised troponin as a coronary event is wrong more often than it is right in a general medical population.
In August 2026 the joint ESC/ACC/AHA/WHF task force published the Fifth Universal Definition, and it changed the vocabulary. The numbered types are gone. In their place are three clinical categories — primary, secondary and procedure-related — chosen because the numbers had stopped describing mechanisms cleanly. Primary infarction now covers every acute coronary pathology rather than atherothrombosis alone, which finally gives spontaneous coronary artery dissection, coronary embolism and vasospasm a settled home. Type 3 is gone entirely, for limited use in practice. Types 4a, 4b, 4c and 5 are one category with one set of criteria, and late stent or graft failure has moved out of it into primary infarction because beyond 30 days it reflects new disease rather than the procedure. And the 99th percentile is now sex-specific, because a single shared cut-off systematically under-recognises myocardial injury in women.
The change with the sharpest practical edge is to secondary infarction. Under the Fourth Universal Definition, an oxygen supply–demand imbalance together with acute injury and ischaemic evidence was enough: tachycardia, a troponin rise and some chest discomfort made a type 2. The Fifth requires more — obstructive coronary artery disease without acute coronary pathology, and/or a new or presumed new regional wall motion abnormality or absence of viable myocardium. That is a demand for objective evidence, and it will reclassify a large number of patients who used to be labelled type 2 on clinical impression alone. This page’s mechanism selector therefore offers the supply–demand case twice, with and without those findings, because the difference between them is now the difference between a classified infarction and an unclassified one.
Why the category matters more than the label: because the three are managed differently. Primary infarction is what the entire acute coronary syndrome apparatus was built for — antithrombotic therapy, risk stratification with the GRACE score, and revascularisation. Secondary infarction is treated by correcting the precipitant: slow the rate, support the blood pressure, correct the hypoxaemia, transfuse the bleeding. No trial has ever tested an antithrombotic or invasive strategy specifically in secondary infarction, so importing the primary pathway is evidence-free and carries bleeding risk in patients who are usually older and sicker. Prognosis does not track the intuition either. At one year, cardiovascular death or infarction affected 17% of primary and 14% of secondary cases; at five years, all-cause mortality was 31% against 59%. The gap is competing non-cardiovascular death, and it says that these are very unwell people, not that the diagnosis is a soft one.
Finally, what this page depends on and cannot supply. It does not know your assay, and every judgement here rests on two assay-specific numbers: the sex-specific 99th percentile and the delta that counts as a significant rise or fall. Get them from your own laboratory, use the hs-troponin delta calculator for the serial change rather than comparing values by eye, and check the units on the report first — ng/L and ng/mL differ by a thousandfold, which is what the troponin I and troponin T converters are for. If kidney function is impaired, read the result on the troponin in renal impairment interpreter instead, because a chronically raised troponin in chronic kidney disease is the single commonest reason a troponin is misread.
Frequently asked questions
What is the difference between myocardial injury and myocardial infarction?
Myocardial injury is a cardiac troponin above the 99th percentile upper reference limit, whatever the cause — the Fifth Universal Definition puts it as “an elevated cardiac troponin I or T level with at least one value above the 99th percentile upper reference limit (URL) regardless of the underlying cause”. Myocardial infarction requires two things on top of that: the injury must be acute, shown by a rise and/or fall across serial samples, and there must be evidence of acute myocardial ischaemia — ischaemic symptoms, new ischaemic ECG changes or new pathological Q waves, imaging evidence of acute coronary pathology, or a new regional wall motion abnormality or new loss of viable myocardium in an ischaemic pattern. A raised troponin without those is injury, not infarction, and it is common: acute non-ischaemic injury and secondary infarction together account for around half of all troponin elevations in unselected hospitalised patients.
Is there a Fifth Universal Definition of Myocardial Infarction?
Yes. The Fifth Universal Definition of Myocardial Infarction was published on 28 August 2026 by the joint ESC/ACC/AHA/WHF task force, simultaneously in the European Heart Journal, Circulation and JACC, and it supersedes the Fourth Universal Definition of 2018. Its largest change is to the classification: the numbered types 1, 2, 3, 4a, 4b, 4c and 5 are replaced by three clinical categories — primary, secondary and procedure-related myocardial infarction. It also makes the 99th percentile sex-specific, removes type 3, unifies the procedural types into one, redefines MINOCA as a working diagnosis, and introduces dedicated ICD-11 codes. This page implements the Fifth and shows the Fourth’s numbering alongside it, because existing records and ICD-10 coding are written in the old numbers.
What is the difference between type 1 and type 2 myocardial infarction?
Type 1, now called primary myocardial infarction, is caused by an acute coronary pathology — classically plaque rupture or erosion with thrombus, and in the Fifth Universal Definition also spontaneous coronary artery dissection, coronary embolism, vasospasm and late stent or graft failure. Type 2, now secondary myocardial infarction, is caused by an oxygen supply–demand imbalance from an acute non-coronary illness: tachyarrhythmia, hypotension, hypoxaemia, anaemia, haemorrhage, sepsis. The Fifth Universal Definition additionally requires objective evidence for the secondary category — obstructive coronary disease without acute coronary pathology, and/or a new or presumed new regional wall motion abnormality. They are managed completely differently: primary infarction follows the acute coronary syndrome pathway, while secondary infarction is treated by correcting the precipitant, and no trial has tested an antithrombotic or revascularisation strategy specifically in secondary infarction.
Can a raised troponin that is not changing be a heart attack?
Not on the definition. Acute myocardial infarction requires acute myocardial injury, and acute myocardial injury is defined as a rise and/or fall with at least one value above the sex-specific 99th percentile. A troponin that is raised but genuinely flat across appropriately spaced serial samples is chronic myocardial injury — a real abnormality with real prognostic weight, and not an infarction. Two traps look like flatness and are not: samples drawn too close together to have separated, and a late presentation caught on the plateau of a curve that rose days ago. Use the interval your assay’s delta was derived for, and check for a previous troponin, which settles the question in one step.
Which is more common, type 1 or type 2 myocardial infarction?
Type 2 — secondary — infarction occurs more frequently than type 1, and above the age of 75 the two are at least equally prevalent. In emergency department patients with suspected acute coronary syndrome the reported prevalence of type 2 infarction is around 12%, and where troponin is measured without a clinical indication the prevalence of myocardial injury is about 4.6%. In one cohort of nearly 5,700 hospitalised patients, 62% had an abnormal high-sensitivity troponin but only 6.1% received a final diagnosis of type 1 infarction. That is why the default reading of a raised troponin as a coronary event is wrong more often than right in a general medical population.
Why does a troponin have to be repeated?
Because a single value establishes myocardial injury and cannot establish whether it is acute or chronic, and that distinction gates everything that follows — infarction of any category is built on acute injury. One number, however high, does not demonstrate a rise or a fall. A second sample at your assay’s own interval answers it, read with the hs-troponin delta calculator or through an accelerated pathway such as the 0/1-hour algorithm. Looking for a previous troponin on the same patient is worth doing first: an old result at the same level converts the finding into a chronic elevation immediately.
Related calculators
References
- Fifth Universal Definition of Myocardial Infarction (2026). On behalf of the joint European Society of Cardiology / American College of Cardiology / American Heart Association / World Heart Federation Task Force for the Universal Definition of Myocardial Infarction. Eur Heart J. Published 28 August 2026, doi:10.1093/eurheartj/ehag101; simultaneously in Circulation (doi:10.1161/CIR.0000000000001477) and JACC (doi:10.1016/j.jacc.2026.07.025). Myocardial injury as “an elevated cardiac troponin I or T level with at least one value above the 99th percentile upper reference limit (URL) regardless of the underlying cause”; acute myocardial injury as “a rise and/or fall in cardiac troponin I or T with at least one value above the sex-specific 99th percentile URL”; infarction as acute myocardial injury “and one or more of the following: symptoms or other evidence of acute myocardial ischaemia that include new ischaemic changes or pathological Q waves on the electrocardiogram (ECG); imaging evidence of an acute coronary pathology; or new loss of viable myocardium or a new regional wall motion abnormality in a pattern consistent with an ischaemic aetiology”; the replacement of types 1 to 5 by primary, secondary and procedure-related categories; secondary infarction requiring “obstructive coronary artery disease without acute coronary pathology and/or new or presumed new regional wall motion abnormality or absence of viable myocardium”; procedure-related infarction as a “coronary complication within 30 days of a cardiac procedure” with late stent or graft failure “excluded as a procedural complication as it typically reflects de novo disease”; type 3 “term removed” for “limited use in clinical practice”; sex-specific 99th percentiles “to avoid systematic bias”; and chronic myocardial injury “up to five times more frequent with cardiac troponin T than cardiac troponin I”.
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269 (simultaneously Circulation 2018;138(20):e618–e651). Myocardial injury as detection of a cTn above the 99th percentile URL, acute when there is a rise and/or fall and chronic when the elevation is persistent; the five items of clinical evidence of acute myocardial ischaemia; types 1, 2, 3, 4a, 4b, 4c and 5, with type 4a requiring a cTn above five times the 99th percentile URL from a normal baseline (or a rise above 20% from a raised one) and type 5 above ten times the 99th percentile URL within 48 hours of coronary artery bypass grafting. Superseded by the Fifth Universal Definition; retained here because clinical records and ICD-10 coding still use its numbering.
- Rafiudeen R, Barlis P, White HD, van Gaal W. Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin. Eur Cardiol Rev. 2022;17:e03. “Type 2 MI occurs more frequently than type 1 MI”; in a cohort of almost 5,700 hospitalised patients “62% had an abnormal hsTn, and there was dynamic change in 24%. However, only 6.1% had a final diagnosis of type 1 MI”.
- Chapman AR, Taggart C, Boeddinghaus J, Mills NL, Fox KAA. Type 2 myocardial infarction: challenges in diagnosis and treatment. Eur Heart J. 2025;46(6):504–517. “Type 2 MI occurs without atherothrombosis, where there is evidence of a reduction in myocardial oxygen supply or an unmet increase in myocardial oxygen demand”; prevalence 12.3% among emergency department patients with suspected acute coronary syndrome and 4.6% for myocardial injury where troponin was measured without a clinical indication; “Type 2 MI is as prevalent as type 1 MI in those over the age of 75 years”; one-year cardiovascular death or infarction 17% in type 1 against 14% in type 2 with five-year all-cause mortality 31% against 59%; “No dedicated trials focused exclusively on treatment strategies in patients with type 2 MI have been undertaken”.
- Taggart C, Chapman AR. Cardiac troponin and the diagnosis of type 2 myocardial infarction and acute non-ischaemic myocardial injury. J Lab Precis Med. 2024;9:5. “Acute non-ischaemic myocardial injury and type 2 myocardial infarction are responsible for around half of all measurable cardiac troponin elevations in unselected hospitalised patients.”
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.